Development of a method to measure preβHDL and αHDL apoA-I enrichment for stable isotopic studies of HDL kinetics

Lipids

Volumn 47, Issue 10, 2012, Pages 1011-1018

  Li, Xuefei ^a   Stolinski, Michael ^b   Umpleby, A Margot ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

HDL; ApoA I kinetics; Electrophoresis; Human; Mass spectrometry; Pre HDL; Stable isotopes

Indexed keywords

APOLIPOPROTEIN A1; CARBON 13; HIGH DENSITY LIPOPROTEIN; ISOTOPE; LEUCINE; PRE ALPHA HIGH DENSITY LIPOPROTEIN; PRE BETA HIGH DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ADULT; AGAR GEL ELECTROPHORESIS; ANALYTIC METHOD; ARTICLE; CATABOLISM; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; ISOTOPE ANALYSIS; KINETICS; LIPOPROTEIN METABOLISM; MALE; MASS FRAGMENTOGRAPHY; MEASUREMENT; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; STABLE ISOTOPE METHODOLOGY;

APOLIPOPROTEIN A-I; CARBON ISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; KINETICS; LEUCINE; LIPOPROTEINS, HDL; MALE;

EID: 84866734080     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-012-3703-0     Document Type: Article

References (30)

1. Barter PJ (2000) Hugh sinclair lecture: the regulation and remodelling of HDL by plasma factors. Atheroscler Suppl 4(3): 39-47
2. Rye KA, Barter PJ (2004) Formation and metabolism of prebetamigrating, lipid-poor apolipoprotein A-I. Arterioscler Thromb Vasc Biol 24:421-428
3. Huang Y, von Eckardstein A, Wu S, Maeda N, Assmann G (1994) A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells. Proc Natl Acad Sci USA 91:1834-1838
4. Miida T, Sakai K, Ozaki K, Nakamura Y, Yamaguchi T, Tsuda T, Kashiwa T, Murakami T, Inano K, Okada M (2000) Bezafibrate increases prebeta 1-HDL at the expense of HDL2b in hypertriglyceridemia. Arterioscler Thromb Vasc Biol 20:2428-2433
5. Moyad MA, Merrick GS (2007) Cholesterol, cholesterol-lowering agents/statins, and urologic disease: part VI-the recent rise and fall of the HDL-boosting drug torceptrapib. Urol Nurs 27:169-173
6. Asztalos BF, Roheim PS, Milani RL, Lefevre M, McNamara JR, Horvath KV, Schaefer EJ (2000) Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 20:2670-2676
7. Cheung MC, Brown BG, Wolf AC, Albers JJ (1991) Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res 32:383-394
8. Xu Y, Fu M (2003) Alterations of HDL subclasses in hyperlipidemia. Clin Chim Acta 332:95-102
9. Miida T, Yamaguchi T, Tsuda T, Okada M (1998) High prebeta1-HDL levelsinhypercholesterolemia are maintainedby probucol but reduced by a low-cholesterol diet. Atherosclerosis 138:129-134
10. Yang Y, Yan B, Fu M, Xu Y, Tian Y (2005) Relationship between plasma lipid concentrations and HDL subclasses. Clin Chim Acta 354:49-58
11. Cohn JS, Wagner DA, Cohn SD, Millar JS, Schaefer EJ (1990) Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding. J Clin Invest 85(3):804-811
12. Ikewaki K, Rader DJ, Schaefer JR, Fairwell T, Zech LA, Brewer HB Jr (1993) Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods. J Lipid Res 34:2207-2215
13. Kunitake ST, Kane JP (1982) Factors affecting the integrity of high density lipoproteins in the ultracentrifuge. J Lipid Res 23:936-940
14. Cheung MC, Wolf AC (1988) Differential effect of ultracentrifugation on apolipoprotein A-I-containing lipoprotein subpopulations. J Lipid Res 29:15-25
15. Cheung MC, Albers JJ (1979) Distribution of cholesterol and apolipoprotein A-I and A-II in human high density lipoprotein subfractions separated by CsCl equilibrium gradient centrifugation: evidence for HDL subpopulations with differing A-I/A-II molar ratios. J Lipid Res 20:200-207
16. Dwyer KP, Barrett PH, Chan D, Foo JI, Watts GF, Croft KD (2002) Oxazolinone derivative of leucine for GC-MS: a sensitive and robust method for stable isotope kinetic studies of lipoproteins. J Lipid Res 43:344-349
17. Ford GC, Cheng KN, Halliday D (1985) Analysis of (1-13C)leucine and (13C)KIC in plasma by capillary gas chromatography/mass spectrometry in protein turnover studies. Biomed Mass Spectrom 12:432-436
18. Ishida BY, Frolich J, Fielding CJ (1987) Prebeta-migrating high density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer. J Lipid Res 28:778-786
19. Ramakrishnan R (2006) Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments. J Lipid Res 47:2738-2753
20. Umpleby AM, Das S, Stolinski M, Shojaee-Moradie F, Jackson NC, Jefferson W, Crabtree N, Nightingale P, Shahmanesh M (2005) Low density lipoprotein apolipoprotein B metabolism in treatment-naive HIV patients and patients on antiretroviral therapy. Antivir Ther 10:663-670
21. Pearson TC, Guthrie DL, Simpson J, Chinn S, Barosi G, Ferrant A, Lewis SM, Najean Y (1995) Interpretation of measured red cell mass and plasma volume in adults: Expert Panel on Radionuclides of the International Council for Standardization in Haematology. Br J Haematol 89:748-756
22. Asztalos BF, Sloop CH, Wong L, Roheim PS (1993) Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations. Biochim Biophys Acta 41(1169):291-300
23. Wieland H, Seidel D (1973) Improved techniques for assessment of serum lipoprotein patterns. II. Rapid method for diagnosis of type III hyperlipoproteinemia without ultracentrifugation. Clin Chem 19:1139-1141
24. Chétiveaux M, Ouguerram K, Zair Y, Maugère P, Falconi I, Nazih H, Krempf M (2004) New model for kinetic studies of HDL metabolism in humans. Eur J Clin Invest 34(4):262-267
25. Collins P (2008) HDL-C in post-menopausal women: an important therapeutic target. Int J Cardiol 124(3):275-282
26. Nakamura Y, Kotite L, Gan Y, Spencer TA, Fielding CJ, Fielding PE (2004) Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase. Biochemistry 43(46): 14811-14820
27. Castro GR, Fielding CJ (1988) Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein. Biochemistry 27(1):25-29
28. Schaefer EJ, Zech LA, Jenkins LL, Bronzert TJ, Rubalcaba EA, Lindgren FT, Aamodt RL, Brewer HB Jr (1982) Human apolipoprotein A-I and A-II metabolism. J Lipid Res 23:850-862
29. Fisher WR, Venkatakrishnan V, Zech LA, Hall CM, Kilgore LL, Stacpoole PW, Diffenderfer MR, FridayKE, Sumner AE, Marsh JB (1995) Kinetic evidence for both a fast and a slow secretory pathway for apolipoprotein A-I in humans. J Lipid Res 36:1618-1628
30. Chan DC, Barrett PH, Watts GF (2004) Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies. Clin Sci (Lond) 107(3):221-232